Skip to content

Analgesic efficacy of a regional technique (erector spinae plane block) following scoliosis surgery.

ERECTOR SPINAE PLANE CATHETERS IN SCOLIOSIS SURGERY - BEE trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2021-004506-21-ES
Enrollment
40
Registered
2021-10-19
Start date
2021-11-30
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain following scoliosis surgery

Interventions

Trade Name: Levobupivacaine Product Name: Levobupivacaine Pharmaceutical Form: Solution for infusion

Sponsors

Hospital Universitario Fundación Alcorcón
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients older than 16 years old - Elective scoliosis surgery involving more than 4 spaces - ASA I-III - Primary surgery and reinterventions - Idiopathic and degenerative scoliosis Are the trial subjects under 18? yes Number of subjects for this age range: 10 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 10 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria: - Urgent surgery - Infection in the site of surgery - Allergy to any of the drugs used in the study. - Patient refusal - Absence of informed consent - Surgical complication that prevents an adequate follow up (i.e. hemorrhage, delirium, etc.)

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate the analgesic efficacy of erector spinae plane catheters following scoliosis surgery involving more than 4 levels;Secondary Objective: To determine morphine consumption, pain scores, time to first mobilisation, sitting and standing, and hospital stay.;Primary end point(s): Morphine consumption in the first 24 postoperative hours;Timepoint(s) of evaluation of this end point: 24 hours

Secondary

MeasureTime frame
Secondary end point(s): To determine morphine consumption during the first 3 days, pain scores (VAS) at 0,2,6,12,24,48 and 72 hours, time to first mobilisation, sitting and standing, time of hospital stay and development of surgical site infection.;Timepoint(s) of evaluation of this end point: During hospital stay and 30 days after discharge

Countries

Spain

Contacts

Public ContactDepartment of Anesthesiology

Hospital Universitario Fundación Alcorcón

dianarocio.zamudio@salud.madrid.org0034916219891

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026